FDA Adverse Event Malfunction Summary report: N

OPTICROSS 18

MDR report key: 22018099 · Received May 14, 2025

Report

Report Number
2124215-2025-27617
Event Type
Malfunction
Date Received
May 14, 2025
Date of Event
April 12, 2025
Report Date
July 15, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OBJ
UDI-DI
08714729904366
PMA / PMN Number
K160514
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

G4 - PREMARKET / 510(K): K160514, K222568.

Additional Manufacturer Narrative · 0

G4 - PREMARKET / 510(K): K160514, K222568. DEVICE EVALUATED BY MFR: THE DEVICE WAS RETURNED FOR EVALUATION. VISUAL INSPECTION REVEALED NO ISSUES WERE FOUND, AND THE DEVICE APPEARS TO BE IN GOOD CONDITION. MICROSCOPE INSPECTION REVEALED THE TIP WAS DAMAGED. NO OTHER ISSUES WERE IDENTIFIED WITH THE DEVICE.

Description of Event or Problem · 0

IT WAS REPORTED THAT CATHETER BREAK OCCURRED. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED PERIPHERAL ARTERY. AN OPTICROSS 18 WAS SELECTED FOR USE. UPON CROSSING THE LESION, IT WAS NOTED THAT THE CATHETER TIP BROKE. THE DEVICE WAS REMOVED IN ONCE PIECE AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT CATHETER BREAK OCCURRED. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED PERIPHERAL ARTERY. AN OPTICROSS 18 WAS SELECTED FOR USE. UPON CROSSING THE LESION, IT WAS NOTED THAT THE CATHETER TIP BROKE. THE DEVICE WAS REMOVED IN ONCE PIECE AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1881845 OPTICROSS 18 CATHETER, ULTRASOUND, INTRAVASCULAR OBJ BOSTON SCIENTIFIC CORPORATION H7493932800180 0035278928 08714729904366

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown